 Lymphoproliferative Disorders
"Lymphoproliferative Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders characterized by proliferation of lymphoid tissue, general or unspecified.
| Descriptor ID |
D008232
|
| MeSH Number(s) |
C15.604.515 C20.683.515
|
| Concept/Terms |
Lymphoproliferative Disorders- Lymphoproliferative Disorders
- Disorder, Lymphoproliferative
- Disorders, Lymphoproliferative
- Lymphoproliferative Disorder
X-Linked Lymphoproliferative Disorder- X-Linked Lymphoproliferative Disorder
- Disorder, X-Linked Lymphoproliferative
- Disorders, X-Linked Lymphoproliferative
- Lymphoproliferative Disorder, X-Linked
- Lymphoproliferative Disorders, X-Linked
- X Linked Lymphoproliferative Disorder
- X-Linked Lymphoproliferative Disorders
- Epstein-Barr Virus Infection, Familial Fatal
- Epstein Barr Virus Infection, Familial Fatal
- Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males
- Epstein Barr Virus Induced Lymphoproliferative Disease In Males
- Familial Fatal Epstein-Barr Infection
- Familial Fatal Epstein Barr Infection
- Immunodeficiency 5
- Immunodeficiency 5s
- Duncan's Syndrome
- Lymphoproliferative Disease, X-Linked
- Disease, X-Linked Lymphoproliferative
- Diseases, X-Linked Lymphoproliferative
- Lymphoproliferative Disease, X Linked
- Lymphoproliferative Diseases, X-Linked
- X-Linked Lymphoproliferative Diseases
- Lymphoproliferative Syndrome, X-Linked, 1
- Purtilo Syndrome
- Purtilo Syndromes
- Syndrome, Purtilo
- Syndromes, Purtilo
- X-Linked Lymphoproliferative Disease
- X Linked Lymphoproliferative Disease
- X-Linked Lymphoproliferative Syndrome
- Lymphoproliferative Syndrome, X-Linked
- Lymphoproliferative Syndromes, X-Linked
- Syndrome, X-Linked Lymphoproliferative
- Syndromes, X-Linked Lymphoproliferative
- X Linked Lymphoproliferative Syndrome
- X-Linked Lymphoproliferative Syndromes
- Duncan Disease
- Disease, Duncan
- Immunodeficiency, X-Linked Progressive Combined Variable
- Immunodeficiency, X Linked Progressive Combined Variable
|
Below are MeSH descriptors whose meaning is more general than "Lymphoproliferative Disorders".
Below are MeSH descriptors whose meaning is more specific than "Lymphoproliferative Disorders".
This graph shows the total number of publications written about "Lymphoproliferative Disorders" by people in this website by year, and whether "Lymphoproliferative Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1984 | 0 | 1 | 1 | | 1987 | 1 | 0 | 1 | | 1988 | 0 | 1 | 1 | | 1996 | 0 | 1 | 1 | | 1997 | 1 | 1 | 2 | | 1999 | 0 | 1 | 1 | | 2001 | 2 | 0 | 2 | | 2002 | 1 | 0 | 1 | | 2003 | 1 | 0 | 1 | | 2004 | 1 | 0 | 1 | | 2005 | 2 | 0 | 2 | | 2006 | 1 | 0 | 1 | | 2010 | 1 | 0 | 1 | | 2016 | 1 | 0 | 1 | | 2021 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Lymphoproliferative Disorders" by people in Profiles.
-
Pearse WB, Petrich AM, Gordon LI, Karmali R, Winter JN, Ma S, Kaplan JB, Behdad A, Klein A, Jovanovic B, Helenowski I, Smith SM, Evens AM, Pro B. A phase I/II trial of brentuximab vedotin plus rituximab as frontline therapy for patients with immunosuppression-associated CD30+ and/or EBV?+?lymphomas. Leuk Lymphoma. 2021 12; 62(14):3493-3500.
-
Small S, Barnea Slonim L, Williams C, Karmali R. B Cell Lymphomas of the GI Tract. Curr Gastroenterol Rep. 2021 May 08; 23(7):9.
-
Wewel JT, Harbhajanka A, Kasliwal MK, Ahuja SK, Loew JM, Fontes RB. Post-transplant lymphoproliferative disorder of the cervical spine mimicking an epidural abscess. J Clin Neurosci. 2016 Jul; 29:175-8.
-
Evens AM, David KA, Helenowski I, Nelson B, Kaufman D, Kircher SM, Gimelfarb A, Hattersley E, Mauro LA, Jovanovic B, Chadburn A, Stiff P, Winter JN, Mehta J, Van Besien K, Gregory S, Gordon LI, Shammo JM, Smith SE, Smith SM. Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era. J Clin Oncol. 2010 Feb 20; 28(6):1038-46.
-
Goldfarb JM, Larson ML, Venugopal P, Gregory SA. Posttransplant lymphoproliferative disorder: extranodal marginal zone lymphoma occurring after renal transplantation. Clin Adv Hematol Oncol. 2006 Aug; 4(8):600-4; discussion 604-6.
-
Gattuso P, Manosca F. Fine-needle aspiration of posttransplant lymphoproliferative disorders: a review. Diagn Cytopathol. 2005 Oct; 33(4):273-8.
-
Anantharaju A, Nauth J, Al-Masri H, Kennedy M, Mobarhan S, Shah N, Leya J. Posttransplantation lymphoproliferative disorder. Gastrointest Endosc. 2005 Feb; 61(2):288-9.
-
Boggio L, Green D. Coagulopathies associated with lymphoproliferative disorders. Curr Hematol Rep. 2004 Jan; 3(1):1-4.
-
Kempf W, Kadin ME, Dvorak AM, Lord CC, Burg G, Letvin NL, Koralnik IJ. Endogenous retroviral elements, but not exogenous retroviruses, are detected in CD30-positive lymphoproliferative disorders of the skin. Carcinogenesis. 2003 Feb; 24(2):301-6.
-
Porcu P, Eisenbeis CF, Pelletier RP, Davies EA, Baiocchi RA, Roychowdhury S, Vourganti S, Nuovo GJ, Marsh WL, Ferketich AK, Henry ML, Ferguson RM, Caligiuri MA. Successful treatment of posttransplantation lymphoproliferative disorder (PTLD) following renal allografting is associated with sustained CD8(+) T-cell restoration. Blood. 2002 Oct 01; 100(7):2341-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|